Cartilage Repair Market - By Modality (Cell Based, Non-cell Based), By Type (Hyaline Cartilage, Fibrocartilage), By Application (Knee, Hip), By End-use (Hospitals and Clinics, Ambulatory Surgical Centers)

Description

List of Tables

Cartilage Repair Market size is estimated to expand at over 10% CAGR from 2023-2032, driven by the rise in sports-related injuries along with the subsequent need for advanced solutions for optimal recovery and joint function. Rising advances in regenerative medicine and surgical techniques offer innovative interventions to athletes for sustained performance. The higher emphasis on sports-related injury prevention and comprehensive rehabilitation is further fueling the adoption of cartilage repair therapies.

Moreover, the jump in ongoing business strategies, such as collaborations and acquisitions between healthcare institutions, research organizations, and industry players will facilitate the development and commercialization of innovative cartilage repair solutions, propelling the market growth. To cite an instance, in November 2023, Smith+Nephew acquired CartiHeal, the company producing Agili-C, a cutting-edge sports medicine treatment for knee cartilage regeneration.

The cartilage repair industry is segmented into modality, type, application, end-use, and region.

Based on type, the fibrocartilage repair market generated substantial revenue in 2022 and is projected to hit 10.4% CAGR from 2023-2032. The rising prevalence of joint injuries and degenerative conditions is spurring the development of targeted fibrocartilage repair strategies. Moreover, the strong commitment towards addressing specific cartilage repair challenges, enhancing the patient outcomes, and driving advancements in the broader field of orthopedic regenerative medicine will propel the segment growth.

In terms of end-use, the cartilage repair industry from the ambulatory surgical centers (ASCs) segment is set to witness 10.5% growth rate between 2023 and 2032 owing to the rise in minimally invasive cartilage repair techniques. ASCs offer a convenient and cost-effective setting for cartilage repair procedures. Furthermore, the surging demand for reduced hospitalization and quicker recovery times is likely to fuel the patient preference for cartilage repair treatment at ASCs.

Regionally, the Asia Pacific cartilage repair market is estimated to expand at 12.4% CAGR from 2023-2032. The increasing sports-related injuries, the rising aging population, and the growing awareness of advanced orthopedic treatments is boosting the demand for cartilage repair solutions. Additionally, the higher advancements in regenerative medicine and orthopedic technologies is fueling the adoption of innovative cartilage repair therapies in the region.

Moreover, the surge in research efforts focused on enhancing the efficiency of cartilage repair materials may augment the regional industry outlook. For instance, in May 2023, The City University of Hong Kong joined forces with the China Resources Research Institute of Science and Technology and the Shenzhou Space Biotechnology Group to launch joint scientific experiments to test samples of new cartilage repair materials for effectiveness in the outer space.

Product Code: 7092

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & working
1.3 Data collection
1.4 Base estimates & workings
1.5 Forecast calculations
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global cartilage repair market 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Modality trends
- 2.1.4 Type trends
- 2.1.5 Application trends
- 2.1.6 End-use trends

Chapter 3 Cartilage Repair Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory scenario
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Increasing incidence of osteoarthritis
  - 3.5.1.2 Rise in sports-related injuries
  - 3.5.1.3 Technological advancements
  - 3.5.1.4 Rise in geriatric population
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 High costs associated with cartilage repair procedures
3.6 Growth potential analysis
- 3.6.1 By modality
- 3.6.2 By type
- 3.6.3 By application
- 3.6.4 By end-use
3.7 Future market trends
3.8 Reimbursement scenario
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022

Chapter 5 Cartilage Repair Market Size and Forecast, By Modality, 2018-2032 (USD Million)

5.1 Key trends, by modality
5.2 Cell-Based
- 5.2.1 Chondrocyte transplantation
- 5.2.2 Growth factors
- 5.2.3 Other cell-based modalities
5.3 Non-cell based
- 5.3.1 Tissue scaffolds
- 5.3.2 Cell-free composites

Chapter 6 Cartilage Repair Market Size and Forecast, By Type, 2018-2032 (USD Million)

6.1 Key trends, by type
6.2 Hyaline cartilage
6.3 Fibrocartilage

Chapter 7 Cartilage Repair Market Size and Forecast, By Application, 2018-2032 (USD Million)

7.1 Key trends, by application
7.2 Knee
7.3 Hip
7.4 Other applications

Chapter 8 Cartilage Repair Market Size and Forecast, By End-use, 2018-2032 (USD Million)

8.1 Key trends, by end-use
8.2 Hospitals and clinics
8.3 Ambulatory surgical centers

Chapter 9 Cartilage Repair Market Size and Forecast, By Region, 2018-2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 Zimmer Biomet
10.2 Smith & Nephew Plc
10.3 Arthrex, Inc.
10.4 Conmed Corporation
10.5 B. Braun Melsungen AG
10.6 Stryker Corporation
10.7 Vericel Corporation
10.8 Collagen Solutions LLC
10.9 Anika Therapeutics, Inc.
10.10 Johnson & Johnson Services, Inc.
10.11 Becton, Dickinson and Company